Injective Protocol (INJ) rose 1.07% in the past 24 hours to reach $7.62, according to market data as of October 3, 2026. The move extended a period of notable strength for the asset over the longer term.
Over the trailing 30 days, INJ has climbed 56.05%, a gain that stands in contrast to the more subdued short-term picture. The token slipped 2.89% over the past seven days, suggesting some consolidation following its sharper monthly advance.
Injective Protocol carries a market capitalization of $0.76 billion at the current price. The figure reflects the token's standing as a mid-tier asset within the broader cryptocurrency market.
The daily uptick alongside a pullback on the weekly timeframe points to mixed near-term momentum, even as the 30-day performance remains one of the more prominent moves in the asset's recent trading history.
